Anodyne Nanotech, Inc

Anodyne Nanotech, Inc company information, Employees & Contact Information

Anodyne is a venture-backed, clinical-stage biotech company focused on simplifying chronic care for all stakeholders. We specialize in the transdermal delivery of multi-milligram doses and complex formulations, enabling easier access to both existing therapies and emerging large molecule treatments. The HeroPatch, our proprietary technology represents a breakthrough in drug delivery. By transdermally delivering large molecules, it enables tunable pharmacokinetic profiles, new formulations using APIs in dry form, room temperature stability, and combination therapies of next-generation therapeutics. Our product pipeline is dedicated to addressing the unmet needs of chronic diseases, with an initial focus on obesity. We are committed to delivering innovative solutions that significantly impact patients’ lives. Anodyne is actively expanding its pipeline through both internal clinical development and strategic external partnerships, maximizing the commercial potential and clinical impact of our advanced drug delivery platform.

Company Details

Employees
19
Founded
-
Address
Boston, Ma 02155, Us
Email
in****@****tch.com
Industry
Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
In-Vitro Diagnostic Substance Manufacturing
Biological Product (except Diagnostic) Manufacturing
Keywords
Malden.
HQ
Boston, MA
Looking for a particular Anodyne Nanotech, Inc employee's phone or email?

Anodyne Nanotech, Inc Questions

News

Anodyne Nanotech Drives Major Advancement in the Treatment of Sarcopenia with Novel Muscle-Preserving Therapy - Yahoo Finance

Anodyne Nanotech Drives Major Advancement in the Treatment of Sarcopenia with Novel Muscle-Preserving Therapy Yahoo Finance

Anodyne Nanotech Appoints Jeff Mihm to its Board of Directors - citybiz

Anodyne Nanotech Appoints Jeff Mihm to its Board of Directors citybiz

Anodyne Nanotech Achieves Breakthrough in Transdermal Delivery of GLP-1 Drugs - Business Wire

Anodyne Nanotech Achieves Breakthrough in Transdermal Delivery of GLP-1 Drugs Business Wire

Top Anodyne Nanotech, Inc Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant